Published in Int J Clin Rheumtol on June 01, 2011
Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science (1998) 13.64
Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A (2003) 9.15
Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res (2000) 8.69
Dendrimers in biomedical applications--reflections on the field. Adv Drug Deliv Rev (2005) 3.39
Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest (2003) 3.04
Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum (2010) 2.52
Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol (1998) 2.50
Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis. J Clin Microbiol (1998) 2.47
Evolution of Chlamydia trachomatis diversity occurs by widespread interstrain recombination involving hotspots. Genome Res (2006) 2.32
The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol Rev (2009) 2.23
Molecular basis defining human Chlamydia trachomatis tissue tropism. A possible role for tryptophan synthase. J Biol Chem (2002) 2.23
Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum (1991) 2.10
Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States. J Bacteriol (2004) 1.94
Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations. J Infect Dis (2008) 1.93
Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis (1998) 1.89
Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano Lett (2006) 1.80
Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides. J Antibiot (Tokyo) (1988) 1.78
Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect Immun (2004) 1.68
Heat shock response of murine Chlamydia trachomatis. J Bacteriol (1990) 1.62
Chlamydia trachomatis serovar differentiation by direct sequence analysis of the variable segment 4 region of the major outer membrane protein gene. Infect Immun (1992) 1.60
Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect Immun (1995) 1.54
Longitudinal assessment of infecting serovars of Chlamydia trachomatis in Seattle public health clinics: 1988-1996. Sex Transm Dis (2003) 1.54
Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab. Arthritis Rheum (2009) 1.51
Transformation and isolation of allelic exchange mutants of Chlamydia psittaci using recombinant DNA introduced by electroporation. Proc Natl Acad Sci U S A (2008) 1.45
Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum (1995) 1.43
Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother (2001) 1.43
Interstrain gene transfer in Chlamydia trachomatis in vitro: mechanism and significance. J Bacteriol (2007) 1.41
Chlamydia pneumoniae--a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis (1994) 1.37
Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother (2000) 1.35
Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am (2009) 1.35
Chlamydophila pneumoniae. Clin Microbiol Infect (2009) 1.31
Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb Pathog (1997) 1.30
Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection. Mol Microbiol (2001) 1.30
No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum (1999) 1.28
Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections. Microb Pathog (2004) 1.27
Arthritis associated with enteric infection. Best Pract Res Clin Rheumatol (2003) 1.26
Chlamydia pneumoniae and atherosclerosis. Cell Microbiol (2004) 1.23
The basis of persistent bacterial infections. Trends Microbiol (2003) 1.21
Viability and gene expression in Chlamydia trachomatis during persistent infection of cultured human monocytes. Med Microbiol Immunol (1998) 1.20
Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines. Bioconjug Chem (2006) 1.19
Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. Microbes Infect (2002) 1.19
Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun (2001) 1.18
Clinical and experimental evidence for persistent Yersinia infection in reactive arthritis. Arthritis Rheum (1999) 1.17
Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels. Bioconjug Chem (2008) 1.13
Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload. Biomaterials (2005) 1.11
Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity. J Infect Dis (2010) 1.09
Recent developments in lipid-based pharmaceutical nanocarriers. Front Biosci (Landmark Ed) (2011) 1.09
Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates. Bioconjug Chem (2005) 1.09
Regulation of carbon metabolism in Chlamydia trachomatis. Mol Microbiol (2000) 1.08
Chlamydia-induced arthritis. Curr Opin Rheumatol (2004) 1.06
Spondyloarthritis: update on pathogenesis and management. Am J Med (2005) 1.04
Genetic diversity of Chlamydia trachomatis and the prevalence of trachoma. Pediatr Infect Dis J (2004) 1.03
Intracellular location of inapparently infecting Chlamydia in synovial tissue from patients with Reiter's syndrome. Immunol Res (1994) 1.02
Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J Rheumatol (2004) 0.96
Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J (1993) 0.94
Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. Arthritis Rheum (1999) 0.94
Molecular biology of infectious agents in chronic arthritis. Rheum Dis Clin North Am (2009) 0.93
Infectious complications of biological therapy. Curr Opin Rheumatol (2009) 0.92
The evolving story of Chlamydia-induced reactive arthritis. Curr Opin Rheumatol (2010) 0.90
Symptomatic acute reactive arthritis after an outbreak of salmonella. J Rheumatol (2008) 0.90
Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue. Microb Pathog (2009) 0.89
The transcript profile of persistent Chlamydophila (Chlamydia) pneumoniae in vitro depends on the means by which persistence is induced. FEMS Microbiol Lett (2008) 0.89
PAMAM-camptothecin conjugate inhibits proliferation and induces nuclear fragmentation in colorectal carcinoma cells. Pharm Res (2010) 0.89
Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial. Ann Rheum Dis (2006) 0.89
Multifunctional Dendrimer-templated Antibody Presentation on Biosensor Surfaces for Improved Biomarker Detection. Adv Funct Mater (2010) 0.86
Detection and frequency of Chlamydia trachomatis DNA in synovial samples from Tunisian patients with reactive arthritis and undifferentiated oligoarthritis. FEMS Immunol Med Microbiol (2009) 0.83
Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection. Rheumatol Int (2009) 0.82
Synovial Chlamydia trachomatis up regulates expression of a panel of genes similar to that transcribed by Mycobacterium tuberculosis during persistent infection. Ann Rheum Dis (2005) 0.82
Molecular mimicry and horror autotoxicus: do chlamydial infections elicit autoimmunity? Expert Rev Mol Med (2006) 0.82
Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab. J Clin Rheumatol (2010) 0.79
Chlamydia pneumoniae infection in preeclampsia. Hypertens Pregnancy (2010) 0.79
PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections. Nanomedicine (2011) 0.78
The pathogenic role of Chlamydia in spondyloarthritis. Curr Opin Rheumatol (2010) 0.78
The potential for the noninvasive delivery of polymeric nanocarriers using propellant-based inhalers in the treatment of Chlamydial respiratory infections. Biomaterials (2010) 0.78
Combination treatment in Chlamydia-triggered reactive arthritis: comment on the article by Carter et al. Arthritis Rheum (2011) 0.77
Serological diagnosis of Chlamydophila pneumoniae infection in Greek COPD patients by microimmunofluorescence and ELISA. Med Sci Monit (2008) 0.76
Treatment of reactive arthritis: a practical guide. BioDrugs (2000) 0.76
Antibiotic treatment and long term prognosis of reactive arthritis. Ann Rheum Dis (2003) 0.76
Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum (2009) 1.77
Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am (2009) 1.35
Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections. Microb Pathog (2004) 1.27
Transcriptome profiling of Saccharomyces cerevisiae during a transition from fermentative to glycerol-based respiratory growth reveals extensive metabolic and structural remodeling. Mol Genet Genomics (2006) 1.26
Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis (2008) 1.21
Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. Microbes Infect (2002) 1.19
Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis. Antimicrob Agents Chemother (2003) 1.17
Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice. Immunology (2005) 1.11
Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Nanomedicine (2013) 1.09
Persistent Chlamydiae and chronic arthritis. Arthritis Res (2001) 1.05
Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunol Med Microbiol (2006) 1.03
Protective immunity to chlamydial genital infection: evidence from animal studies. J Infect Dis (2010) 1.03
Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. J Rheumatol (2002) 1.02
Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells. J Infect Dis (2002) 1.01
Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis. Mol Pharm (2012) 0.99
Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice. Immunology (2004) 0.94
Molecular biology of infectious agents in chronic arthritis. Rheum Dis Clin North Am (2009) 0.93
Infectious agents and multiple sclerosis--are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol (2003) 0.93
New insights into Chlamydia and arthritis. Promise of a cure? Ann Rheum Dis (2013) 0.93
Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci (2004) 0.92
Dendrimer-enabled transformation of Chlamydia trachomatis. Microb Pathog (2013) 0.91
The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microb Pathog (2005) 0.91
Rsf1p, a protein required for respiratory growth of Saccharomyces cerevisiae. Curr Genet (2003) 0.90
The evolving story of Chlamydia-induced reactive arthritis. Curr Opin Rheumatol (2010) 0.90
The molecular genetic basis of mitochondrial malfunction in bladder tissue following outlet obstruction. J Urol (2004) 0.90
Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue. Microb Pathog (2009) 0.89
The transcript profile of persistent Chlamydophila (Chlamydia) pneumoniae in vitro depends on the means by which persistence is induced. FEMS Microbiol Lett (2008) 0.89
Kinematics of intracellular chlamydiae provide evidence for contact-dependent development. J Bacteriol (2009) 0.86
Spermatogenetic expression of RNA-binding motif protein 7, a protein that interacts with splicing factors. J Androl (2003) 0.85
Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice. Invest Ophthalmol Vis Sci (2004) 0.84
Chlamydia and chronic arthritis. Ann Med (2011) 0.84
Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype. Am J Med Sci (2006) 0.84
Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice. Invest Ophthalmol Vis Sci (2007) 0.84
Reactive arthritis and internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 0.83
Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain. Int J Med Microbiol (2008) 0.83
Human herpesvirus 6 and Chlamydia pneumoniae as etiologic agents in multiple sclerosis - a critical review. Microbes Infect (2002) 0.83
Up-regulation of a cellular protein at the translational level by a retrovirus. Proc Natl Acad Sci U S A (2008) 0.83
Molecular mimicry and horror autotoxicus: do chlamydial infections elicit autoimmunity? Expert Rev Mol Med (2006) 0.82
Detection of DNA from a range of bacterial species in the knee joints of dogs with inflammatory knee arthritis and associated degenerative anterior cruciate ligament rupture. Microb Pathog (2007) 0.82
Rsf1p is required for an efficient metabolic shift from fermentative to glycerol-based respiratory growth in S. cerevisiae. Yeast (2009) 0.82
Etiology and pathogenesis of late-onset Alzheimer's disease. Curr Allergy Asthma Rep (2014) 0.81
Biomimetic design in microparticulate vaccines. Biomaterials (2003) 0.80
Regulation of Sam68 activity by small heat shock protein 22. J Cell Biochem (2006) 0.80
The YJR127C/ZMS1 gene product is involved in glycerol-based respiratory growth of the yeast Saccharomyces cerevisiae. Curr Genet (2005) 0.80
Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles. Biomaterials (2011) 0.80
Fate of Chlamydophila pneumoniae in human monocyte-derived dendritic cells: long lasting infection. Microb Pathog (2006) 0.80
Chlamydia trachomatis is present and metabolically active during the remitting phase in synovial tissues from patients with chronic Chlamydia-induced reactive arthritis. Am J Med Sci (2013) 0.80
PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections. Nanomedicine (2011) 0.78
No correlation between giant cell arteritis and Chlamydia pneumoniae infection: investigation of 189 patients by standard and improved PCR methods. J Clin Microbiol (2009) 0.78
The potential for the noninvasive delivery of polymeric nanocarriers using propellant-based inhalers in the treatment of Chlamydial respiratory infections. Biomaterials (2010) 0.78
The pathogenic role of Chlamydia in spondyloarthritis. Curr Opin Rheumatol (2010) 0.78
The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis. Int J Clin Rheumtol (2012) 0.78
Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells. Microb Pathog (2007) 0.77
Analysis of estrogen binding sites of the posterior ligament of the human TMJ. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 0.76
Transmission of Chlamydophila pneumoniae from dendritic cells to macrophages does not require cell-to-cell contact in vitro. J Microbiol Methods (2007) 0.76
Seasonal variation in detection of bacterial DNA in arthritic stifle joints of dogs with cranial cruciate ligament rupture using PCR amplification of the 16S rRNA gene. Vet Microbiol (2009) 0.76
Attack rate of Chlamydia-induced reactive arthritis and effect of the CCR5-Delta-32 mutation: a prospective analysis. J Rheumatol (2013) 0.76
Ultrastructural Analysis of Chlamydia Pneumoniae in the Alzheimer's Brain. Pathogenesis (Amst) (1999) 0.76
Lack of evidence for bacterial infections in skin in patients with systemic sclerosis. Am J Med Sci (2009) 0.75
Functional CCR5 receptor protects patients with arthritis from high synovial burden of infecting Chlamydia trachomatis. Am J Med Sci (2010) 0.75
Cloning of COX4 cDNA from the NZ white rabbit and expression of this gene in bladder smooth muscle following partial outlet obstruction. World J Urol (2002) 0.75
Pathogenesis of autoimmune lacrimal gland disease in MRL/MPJ mice. Adv Exp Med Biol (2002) 0.75